ArticleResearch square2023
Novel Scheme for Defining the Clinical Implications of TP53 Mutations in Myeloid Neoplasia.
Waled Bahaj, Tariq Kewan, Carmelo Gurnari, Arda Durmaz, Ben Ponvilawan, Ishani Pandit, Yasuo Kubota, Olisaemeka D Ogbue, Misam Zawit, Yazan Madanat and 9 more
Open access · greenFull text readPreprint
In one paragraphArticle in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
19 authors at 4 institutions in 2 countries.
Waled BahajCleveland Clinic.
Tariq KewanCleveland Clinic.
Carmelo GurnariCleveland Clinic.
Arda DurmazCleveland Clinic.
Ben PonvilawanCleveland Clinic.
Ishani PanditCleveland Clinic.
Yasuo KubotaCleveland Clinic.
Olisaemeka D OgbueCleveland Clinic.
Misam ZawitCleveland Clinic.
Yazan MadanatUniversity of Texas Southwestern Medical Center.
Taha BatUniversity of Texas Southwestern Medical Center.
Suresh K BalasubramanianWayne State University.
Hussein AwadaCleveland Clinic.
Ramsha AhmedCleveland Clinic.
Minako MoriCleveland Clinic.
Manja MeggendorferMLL Munich Leukemia Laboratory.
Torsten HaferlachMLL Munich Leukemia Laboratory.
Valeria VisconteCleveland Clinic.
Jaroslaw P MaciejewskiCleveland Clinic.
Cleveland Clinic · USMunich Leukemia Laboratory (Germany) · DESouthwestern Medical CenterWayne State University · US
Funding
Therapeutic Implications of Molecular Defects in Bone Marrow FailureR35HL135795 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MACIEJEWSKI, JAROSLAW P. · 2017 to 2023
$5.7MNovel Spliceosomal Defects in Myelodysplastic SyndromesR01HL132071 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MACIEJEWSKI, JAROSLAW P., PADGETT, RICHARD A · 2016 to 2019
$2.4MRNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic TargetR01HL123904 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI JANKOWSKY, ECKHARD, MACIEJEWSKI, JAROSLAW P. · 2015 to 2018
$2.1MInvestigations of Consequences of U2AF1 Mutations in MDSR01HL118281 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MACIEJEWSKI, JAROSLAW P., PADGETT, RICHARD A · 2013 to 2017
$1.9MNHLBI NIH HHS R01 HL118281NHLBI NIH HHS R01 HL123904NHLBI NIH HHS R01 HL132071NHLBI NIH HHS R35 HL135795
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID36945617
PMCPMC10029089
OpenAlexW4323660660
What OpenQuestion holds
Textfull text, public
LicenceCC BY
measurements read56
Read underepoch 390